Physician

Nabila Lehachi Waheed, D.O.

According to 2025 Medicare claims, Nabila Waheed, D.O. (NPI: 1700220183) practices radiation oncology in the Fort Worth-Arlington-Grapevine, TX market, with the plurality of this provider's patient population coming from Tarrant, TX. This provider's primary affiliated billing organization is ONCOLOGY-HEMATOLOGY CONSULTANTS PA (NPI: 1629021159; TIN: 752512142) and primary practice location at 76104-4611. Waheed is affiliated with the UT Southwestern Accountable Care Network (ACO ID: D0211), participating under the REACH model.

Waheed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 295 traditional Medicare patients, billed 11,426 HCPCS/CPT codes, and received $2,210,175 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 368 prescription claims across 190 beneficiaries totaling $5,257 in drug costs, led by Mometasone Furoate (Mometasone Furoate). 2023 DME data shows 14 claims. Open Payments data shows 7 records totaling $926. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $76,777 to $2,210,175. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.